AR109364A1 - ANTIVIRAL COMPOUNDS - Google Patents
ANTIVIRAL COMPOUNDSInfo
- Publication number
- AR109364A1 AR109364A1 ARP170102299A ARP170102299A AR109364A1 AR 109364 A1 AR109364 A1 AR 109364A1 AR P170102299 A ARP170102299 A AR P170102299A AR P170102299 A ARP170102299 A AR P170102299A AR 109364 A1 AR109364 A1 AR 109364A1
- Authority
- AR
- Argentina
- Prior art keywords
- antiviral compounds
- compound
- formula
- useful
- pharmaceutically acceptable
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente descripción se refiere a un compuesto de fórmula (1), (2), (3) y (4), que son útiles en el tratamiento de una infección viral por Retroviridae incluyendo una infección causada por el virus del VIH. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo.The present description refers to a compound of formula (1), (2), (3) and (4), which are useful in the treatment of a viral infection by Retroviridae including an infection caused by the HIV virus. Claim 1: A compound of formula (1) or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662377312P | 2016-08-19 | 2016-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR109364A1 true AR109364A1 (en) | 2018-11-21 |
Family
ID=64499920
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170102299A AR109364A1 (en) | 2016-08-19 | 2017-08-17 | ANTIVIRAL COMPOUNDS |
ARP190102131A AR115865A2 (en) | 2016-08-19 | 2019-07-29 | THERAPEUTIC COMPOUNDS |
ARP190103689A AR117709A2 (en) | 2016-08-19 | 2019-12-16 | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP190102131A AR115865A2 (en) | 2016-08-19 | 2019-07-29 | THERAPEUTIC COMPOUNDS |
ARP190103689A AR117709A2 (en) | 2016-08-19 | 2019-12-16 | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME |
Country Status (2)
Country | Link |
---|---|
AR (3) | AR109364A1 (en) |
HR (1) | HRP20191601T1 (en) |
-
2017
- 2017-08-17 AR ARP170102299A patent/AR109364A1/en unknown
-
2019
- 2019-07-29 AR ARP190102131A patent/AR115865A2/en unknown
- 2019-09-04 HR HRP20191601 patent/HRP20191601T1/en unknown
- 2019-12-16 AR ARP190103689A patent/AR117709A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20191601T1 (en) | 2019-11-29 |
AR117709A2 (en) | 2021-08-25 |
AR115865A2 (en) | 2021-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2019000033A (en) | THERAPEUTIC COMPOUNDS | |
CL2018002528A1 (en) | Anti viral agents of hepatitis b. | |
UY37997A (en) | ANTIVIRAL AGENTS AGAINST HEPATITIS B | |
DOP2021000147A (en) | THERAPEUTIC COMBINATION COMPRISING LAMIVUDINE | |
CY1123570T1 (en) | HEPATITIS B NUCLEAR PROTEIN MODIFIERS | |
CU20150096A7 (en) | AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR HIV TREATMENT | |
CO2019000069A2 (en) | Antiviral agents against hepatitis b | |
DOP2019000201A (en) | HIV INHIBITING COMPOUNDS | |
UY37998A (en) | ANTIVIRAL AGENTS AGAINST HEPATITIS B | |
CO2018009382A2 (en) | Elimination of hepatitis B virus with antiviral agents | |
UY37710A (en) | INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | |
CL2020000487A1 (en) | Antiviral agents against hepatitis b. | |
CO2017007355A2 (en) | Compounds derived from pyrazinecarbozamide and pyrazinecarboxylate for the treatment of hepatitis b virus infection | |
UY38483A (en) | HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS | |
UY35263A (en) | THERAPEUTIC COMPOUNDS | |
CL2020001146A1 (en) | New indole-2-carboxamides substituted with pyrazolopiperidine, of high activity, active against the hepatitis b virus (HBV). | |
CL2020000886A1 (en) | 1-Benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as hiv protease inhibitors. | |
EA201791872A1 (en) | POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
CR20150611A (en) | NOVEDOSAS HETEROARILDIHIDROPIRIMIDINAS UNITED BY BRIDGES IN 6 FOR THE TREATMENT AND PROFILAXIS BY THE VIRUS OF HEPATITIS B | |
EA201791019A1 (en) | POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS | |
CU24525B1 (en) | QUINOLEIN DERIVATIVE TO TREAT AND PREVENT VIRAL INFECTIONS | |
CL2011002830A1 (en) | Compounds derived from haloalkyl heteroaryl benzamides; pharmaceutical composition use of the composition in the treatment of a viral infection, such as hepatitis b and c virus. | |
AR099632A1 (en) | TREATMENT OF A VIRAL INFECTION OF HEPATITIS C, THAT USES A COMBINATION OF COMPOUNDS | |
UY38383A (en) | HETEROCYCLES FUNCTIONALIZED AS ANTIVIRAL AGENTS | |
EA201490213A1 (en) | BENZOFURANE CONNECTIONS FOR THE TREATMENT OF INFECTIONS BY THE HEPATITIS C VIRUS |